Quick Answer
Beam Therapeutics Inc. reported Earnings Per Share Diluted of $0.81 (loss) per share for the year ending 2025.
- Beam Therapeutics Inc. showed an increase of +82.3% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Beam Therapeutics Inc.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2019 to 2025), Beam Therapeutics Inc.'s Earnings Per Share Diluted has grown by 94.2%.
- Historical annual values: Fiscal year 2025: $0.81 (loss) per share | Fiscal year 2024: $4.58 (loss) per share | Fiscal year 2023: $1.72 (loss) per share | Fiscal year 2022: $4.13 (loss) per share | Fiscal year 2021: $5.77 (loss) per share | Fiscal year 2020: $4.19 (loss) per share | Fiscal year 2019: $14.05 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: